Galmed Pharmaceuticals Ltd. (GLMD)
0.833
-0.02
(-1.99%)
USD |
NASDAQ |
Jan 09, 16:00
0.8402
+0.01
(+0.86%)
After-Hours: 20:00
Galmed Pharmaceuticals EPS Diluted (Quarterly): -0.3465 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.892M |
| Total Expenses (Quarterly) | 1.892M |
| Enterprise Value | -14.61M |
| Earnings Yield | -423.3% |
| Normalized Earnings Yield | -354.32 |